Table 1 Demographic and clinical characteristics of the observed population at baseline. Results are stratified by letter improvement 1 month and 4 months after the dexamethasone implant

Sex (female), n (%)

15 (45.4%)

8 (53.3%)

11 (61.1%)

0.54*

10 (58.8%)

9 (56.3%)

1.00*

Age, mean ± SD

68.2 ± 9.7

67.6 ± 12.4

68.6 ± 7.2

0.96°

67.6 ± 11.6

68.8 ± 7.6

0.93°

ETDRS letters, mean ± SD

28.7 ± 16.0

31.9 ± 17.8

26.1 ± 14.3

0.29°

32.5 ± 18.5

25.3 ± 12.4

0.14°

LogMar, mean ± SD

0.59 ± 0.46

0.53 ± 0.50

0.64 ± 0.43

0.26°

0.56 ± 0.57

0.62 ± 0.31

0.15°

SEQ, mean ± SD

0.36 ± 1.14

0.38 ± 1.15

0.33 ± 1.16

0.90°

0.46 ± 1.18

0.25 ± 1.13

0.61°

Pseudophakia, n (%)

15 (45.4%)

5 (33.3%)

10 (55.5%)

0.30*

8 (47.1%)

7 (43.8%)

1.00*

Naïve, n (%)

21 (63.6%)

10 (66.7%)

11 (61.1%)

1.00*

10 (58.8%)

11 (68.8%)

0.72*

Laser treatment, n (%)

14 (42.4%)

9 (60.0%)

5 (27.8%)

0.09*

8 (47.1%)

6 (37.5%)

0.73*